Inogen | INGN - Pre Tax Profit


Inogen reported $-6.06M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Accuray USD 3.23M 6.56M Dec/2024
AngioDynamics USD -6.4M 5.03M Sep/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Baxter International USD -756M 877M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Chart Industries USD -26.7M 70.2M Mar/2026
Cooper Companies USD 116.8M 137.4M Sep/2025
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 169.23M 25.24M Dec/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 113M 27.2M Mar/2026
Masimo USD 71.3M 3.6M Mar/2026
Medtronic USD 2.1B 224M Sep/2025
Orthofix International USD -2.19M 20.07M Dec/2025
Philips EUR 466M 191M Dec/2025
ResMed USD 496.15M 13.77M Dec/2025
Steris USD 257.8M 66.6M Dec/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD 4.68M 29.82M Dec/2025
Teleflex USD 218.94M 657.52M Dec/2025
X T L Biopharmaceuticals USD -385K 168K Dec/2024
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025